Mayes Patrick A相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Discovery of a Selective and Potent Inhibitor of Cyclin-Dependent Kinase 12/13 Employing a Noncovalent Mechanism

利用非共价机制发现一种选择性强、高效的细胞周期蛋白依赖性激酶12/13抑制剂

期刊:ACS Medicinal Chemistry Letters

doi:10.1021/acsmedchemlett.5c00743

Swyka, Robert A; Styduhar, Evan D; Wang, Anlai; Li, Xin; Zhang, Ke; Witten, Michael R; Zhao, Peng; Liang, Michael Z; Atasoylu, Onur; He, Peng; Soderquist, Ryan; Hansbury, Mike; Huo, Lu; Chen, Haiying; Zimmer, Derek; Zhang, Wenliang; Wang, Kathy; Volgina, Alla; Epling, Leslie B; Crowgey, Erin; Kumari, Ekta; Abdollahi, Angela; Zhang, Guofeng; Rupar, Mark; Schaffer, Michael; Mayes, Patrick A; Kim, Sunkyu; Vechorkin, Oleg; Wang, Xiaozhao

细胞生物学

发表日期：2026

文献求助收藏

Correction: Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway

更正：对TRAIL诱导化合物的鉴定突显了小分子ONC201/TIC10作为一种独特的抗癌药物，它能够激活TRAIL通路。

期刊:Molecular Cancer

影响因子:33.9

doi:10.1186/s12943-024-02158-w

Allen, Joshua E; Krigsfeld, Gabriel; Patel, Luv; Mayes, Patrick A; Dicker, David T; Wu, Gen Sheng; El-Deiry, Wafik S

发表日期：2024

文献求助收藏

Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway

TRAIL诱导化合物的鉴定凸显了小分子ONC201/TIC10作为一种独特的抗癌药物，它能够激活TRAIL通路。

期刊:Molecular Cancer

影响因子:33.9

doi:10.1186/s12943-015-0346-9

Allen, Joshua E; Krigsfeld, Gabriel; Patel, Luv; Mayes, Patrick A; Dicker, David T; Wu, Gen Sheng; El-Deiry, Wafik S

发表日期：2015

文献求助收藏

Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma

新型抗B细胞成熟抗原抗体药物偶联物（GSK2857916）选择性诱导多发性骨髓瘤细胞死亡

影响因子:23.1

doi:10.1182/blood-2013-10-535088

Tai, Yu-Tzu; Mayes, Patrick A; Acharya, Chirag; Zhong, Mike Y; Cea, Michele; Cagnetta, Antonia; Craigen, Jenny; Yates, John; Gliddon, Louise; Fieles, William; Hoang, Bao; Tunstead, James; Christie, Amanda L; Kung, Andrew L; Richardson, Paul; Munshi, Nikhil C; Anderson, Kenneth C

多发性骨髓瘤

细胞生物学

免疫/内分泌

发表日期：2014

文献求助收藏

Mitogen-activated protein kinase (MEK/ERK) inhibition sensitizes cancer cells to centromere-associated protein E inhibition

丝裂原活化蛋白激酶（MEK/ERK）抑制可使癌细胞对着丝粒相关蛋白E抑制剂更加敏感

期刊:International Journal of Cancer

影响因子:4.7

doi:10.1002/ijc.27781

Mayes, Patrick A; Degenhardt, Yan Y; Wood, Andrew; Toporovskya, Yana; Diskin, Sharon J; Haglund, Elizabeth; Moy, Christopher; Wooster, Richard; Maris, John M

细胞生物学

发表日期：2013

文献求助收藏

ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation

ATF4在谷氨酰胺缺乏时调节MYC介导的神经母细胞瘤细胞死亡

期刊:Cancer Cell

影响因子:44.5

doi:10.1016/j.ccr.2012.09.021

Qing, Guoliang; Li, Bo; Vu, Annette; Skuli, Nicolas; Walton, Zandra E; Liu, Xueyuan; Mayes, Patrick A; Wise, David R; Thompson, Craig B; Maris, John M; Hogarty, Michael D; Simon, M Celeste

细胞生物学

发表日期：2012

文献求助收藏

Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha.

N-Myc 和缺氧诱导因子 HIF-1α 对神经母细胞瘤肿瘤进展的组合调控

期刊:Cancer Research

影响因子:16.6

doi:10.1158/0008-5472.CAN-10-0740

Qing Guoliang, Skuli Nicolas, Mayes Patrick A, Pawel Bruce, Martinez Daniel, Maris John M, Simon M Celeste

发表日期：2010

文献求助收藏